期刊文献+

巨噬细胞炎性反应蛋白3β复制缺陷型重组腺病毒的构建与鉴定

Construction and characterization of replication deficient adenovirus containing macrophage inflammatory protein 3β gene
下载PDF
导出
摘要 目的构建小鼠巨噬细胞炎性反应因子-3β(mMIP3β)的复制缺陷型重组腺病毒(Ad-mMIP3β),并在体外表达MIP3β。方法通过在细菌BJ5183内同源重组,利用AdEasyTM系统构建Ad-mMIP3β,经过噬斑筛选、PCR鉴定,然后用CsCl不连续密度梯度离心纯化。利用RT-PCR和Western blot方法研究Ad-mMIP3β的体外表达情况。结果成功构建了MIP3β的复制缺陷型重组腺病毒,并检测到分泌到胞外的MIP3β蛋白。结论MIP3β的复制缺陷型重组腺病毒构建成功,为下一步的肿瘤基因治疗研究奠定了基础。 [Objective] To construct the replication deficient adenovirus containing murine macrophage inflammarion protein-3β (Ad-mMIP3β) and express MIP3β in vitro. [Methods] The mMIP3β gene was constructed into the adenoviral backbone plasmid of AdEasyTM system by homologous recombination in bacteria BJ5183. After transfection of such plasmid into mammalian packaging cell lines (HEK293), the viral production (Ad-mMIP3β) was subsequently screened by plaque assay and PCR, eventually purified by double cesium chloride gradient ultracentrifugation. The Ad-mMIP3β expression in vitro was assayed by RT-PCR and Western Blot methods. [Results] The replication deficient adenovirus containing mMIP3β gene was constructed correctly and the protein expressiion was identified. [Conelusion] These results suggested that Ad-mMIP3β constructed correctly would be applied for the following study of cancer gene therapy.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2007年第9期1033-1036,共4页 China Journal of Modern Medicine
基金 国家重点基础研究发展计划("973计划")(2004CB518800)
关键词 mMIP3 β 腺病毒 基因治疗 巨噬细胞炎性反应蛋白 mMIP3β adenovirus gene therapy
  • 相关文献

参考文献13

  • 1HOMEY B,MULLER A,ZLOTNIK A.Chemokines:agents for the immunotherapy of cancer[J].Nat Rev Immunol,2002,2:175-184.
  • 2BELPERIO JA,KEANE MP,ARENBERG DA,et al.CXC chemokines in angiogenesis[J].J Leukoc Biol,2000,68:1-8.
  • 3TETSUHIKO N,HITOSHI H,MASSASHI K,et al.Enhancement of anti-tumor immunity by tumor cells transfected with the secondary lymphoid tissue chemokine EBI-1-ligand chemokine and stromal cell-derived factor-1(chemokine genes[J].Int J Cancer,2001,91:597-606.
  • 4BLEUL CC,FUHLBRIGGE RC,CASASNOVAS JM,et al.A highly efficacious lymphocyte chemoattractant,stromal cell-derived factor 1 (SDF-1)[J].J Exp Med,1996,184:1101-1109.
  • 5PIKINGTON KR,IAN CL,MCCOLL SR.Inhibition of generation of cytotoxic T lymphocyte activity by a CCL19/macrophage inflammatory protein (MIP)-3β antagonist[J].The Journal of Biological Chemistry,2004,279(39):40276-40282.
  • 6NGO VN,TANG HL,CYSTER JG.Epstein-Barr virus-induced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracs naive T cells and activated B cells[J].J Exp Med,1998,188(1):181-191.
  • 7BRAUN SE,CHEN KY,FOSTER RG,et al.The CC chemokine CK(-11/MIP-3(/ELC/Exodus 3 mediates tumor rejection of murine breast cancer cells through NK cells[J].J Immunol,2000,164:4025-4031.
  • 8KIM CH,PELUS LM,WHITE JR,et al.Maerophage-inflammatory protein-3 β/EBI1-ligand chemokine/CK β -11,a CC chemokine,is a chemoattractant with a specificity for macrophage progenitors among myeloid progenitor cells[J].J Immunol,1998,161:2580-2585.
  • 9YOSHIDA R,IMAI T,HIESHIMA K,et al.Molecular cloning of a novel human CC chemokine EBI1-ligand chemokine that is a specific functional ligand for EBI1,CCR7[J].J Biol Chem,1997,272:13803-13809.
  • 10ZHANG WW,FANG X,BRANCH CD,et al.Generation and identification of recombinant adenovirus by liposome-mediated transfection and PCR analysis[J].Biotechniques,1993,15:868-872.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部